Awards conferred for top posters

The American Academy of Dermatology Poster Exhibits Task Force announced the recipients of the 2014 Poster Awards during the 72nd Annual Meeting in Denver. The Academy congratulates all the authors on their outstanding presentations.

1st Place

P7657: Number needed to treat and cost per responder for biologic therapies for the treatment of moderate to severe psoriasis

Richard G. Langley, Dalhousie University, Halifax, Canada; James Signorovitch, Analysis Group, Inc, Boston, Mass., United States; Ke Wang, Global Health Economics and Outcomes Research, AbbVie, North Chicago, Ill., United States; Keith A. Betts, Analysis Group, Inc, Boston, Mass., United States; Murali Sundaram, Global Health Economics and Outcomes Research, AbbVie, North Chicago, Ill., United States; Parvez Mulani, Global Health Economics and Outcomes Research, AbbVie, North Chicago, Ill., United States; Sherry Yan, Analysis Group, Inc, Boston, Mass., United States.

 2nd Place

P8324: Melanoma associated with TNFa inhibitors: A research on adverse drug reactions (RADAR) report

Beatrice Nardone, MD, PhD, department of dermatology, Northwestern University, Chicago, Ill., United States; Dennis P. West, PhD, department of dermatology, Northwestern University, Chicago, Ill., United States; Dennis W. Raisch, PhD, College of Pharmacy, University of New Mexico, Albuquerque, N.M., United States; Gil Abramovici, MD, department of dermatology, Northwestern University, Chicago, Ill., United States; Jeave Reserva, MD, department of dermatology, Northwestern University, Chicago, Ill., United States; Josh A. Hammel, MD, department of dermatology, Northwestern University, Chicago, Ill., United States.

3rd Place

P8398: Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-alfa inhibitors versus methotrexate

Jashin J. Wu, Kaiser Permanente Los Angeles Medical Center, Los Angeles, Calif., United States; Annie Guerin, Analysis Group, Inc, Boston, Mass., United States; Katherine Dea, Analysis Group, Inc, Boston, Mass., United States; Ke Wang, AbbVie Inc, North Chicago, Ill., United States; Murali Sundaram, AbbVie Inc, North Chicago, Ill., United States; Parvez Mulani, AbbVie Inc, North Chicago, Ill., United States.

4th Place

P7571: Immunohistochemical detection of BRAF mutation in melanoma

Michelle Vernali, University of North Carolina School of Medicine, Chapel Hill, N.C., United States; Dan Zedek, MD, department of dermatology, University of North Carolina School of Medicine, Chapel Hill, N.C., United States; David W. Ollila, MD, department of surgical oncology, University of North Carolina School of Medicine, Chapel Hill, N.C., United States; Nancy E. Thomas, MD, PhD, department of dermatology, University of North Carolina School of Medicine, Chapel Hill, N.C., United States.

Honorable Mention

P7622: A population-based study on the association between bullous pemphigoid and neurologic disease

Katherine Brick, MD, Mayo Clinic, Rochester, Minn., United States; Carilyn Wieland, MD, Mayo Clinic, Rochester, Minn., United States; Chad Weaver, MD, Mayo Clinic, Rochester, Minn., United States; Christine Lohse, MS, Mayo Clinic, Rochester, Minn., United States; Lawrence Gibson, MD, Mayo Clinic, Rochester, Minn., United States; Mark Pittelkow, MD, Mayo Clinic, Rochester, Minn., United States; Michael Camilleri, MD, Mayo Clinic, Rochester, Minn., United States.

Return to index.

 

Top